Summary:
A nationwide study led by Kansas State University using genomic data and continuous wearable tracking shows that regular physical activity substantially reduces the impact of high genetic susceptibility to major depressive disorder (MDD). Drawing on multimodal data from the NIH’s All of Us Research Program—including whole-genome sequencing, electronic health records, survey responses, and long-term Fitbit metrics—researchers report that higher daily step counts and greater minutes of moderate-to-vigorous physical activity weaken the link between polygenic risk and clinical symptom severity in adults.
Key Facts:
- Buffering Genetic Risk: Objective wearable data indicate that increased daily movement moderates the association between elevated genetic risk and more severe depressive symptoms.
- Objective Tracking via All of Us: The study relied on longitudinal, device-assessed activity from Fitbit devices rather than self-reported exercise, integrating that telemetry with electronic health records and genome-wide sequencing across a diverse U.S. adult sample.
- Spectrum of Severity: Instead of a binary diagnosis model, researchers assessed symptom severity along a continuum and found that moderate-to-vigorous activity helps prevent escalation from subclinical to more severe depressive symptom burden.
Source: Kansas State University
Major depressive disorder remains a leading cause of disability globally, creating deep personal, social, and economic costs. Large genome-wide association studies (GWAS) have shown that depression is polygenic, influenced by thousands of small genetic variants, yet a high genetic predisposition does not inevitably produce a clinical diagnosis.
Identifying lifestyle factors that can buffer or modify inherited biological vulnerability is a key aim of precision psychiatry. This multi-institutional investigation—led by researchers at Kansas State University with collaborators at the University of Texas at San Antonio, the University of Rhode Island, and Vanderbilt Health—offers objective evidence that habitual physical activity can weaken the phenotypic expression of genetic risk for depression.
Published in Nature Mental Health, the study leverages the All of Us Research Program’s depth of data to test how continuous, real-world movement interacts with polygenic risk scores (PRS) for MDD.
Beyond Binary Diagnoses: Real-World Wearable Metrics
Historically, psychiatric research has often treated depression as present or absent and depended on self-reported physical activity, which is vulnerable to recall and reporting bias. To address these limitations, the research team combined comprehensive electronic health records, whole-genome sequencing, survey responses, and continuous Fitbit-derived movement data collected over extended periods.
Lead investigator Denver Brown, PhD, emphasized the value of this approach for personalized medicine: understanding an individual’s genetic risk can help guide lifestyle conversations—particularly around activity levels that may prevent or lessen depressive symptoms.
The analysis considered both categorical clinical diagnoses and graded symptom severity. That distinction revealed patterns that a simple yes/no diagnostic framework can miss: many people experience varying degrees of symptoms without meeting formal diagnostic thresholds, and those symptom levels matter for quality of life and treatment planning.
Daily Steps and Moderate-to-Vigorous Activity as Genetic Buffers
The investigators evaluated daily step counts and total minutes of moderate-to-vigorous physical activity (MVPA) as practical, device-measured indicators of movement. Across several analytical models, both higher step totals and greater MVPA consistently moderated the relationship between genetic vulnerability and symptom burden.
Among adults with high polygenic risk for MDD, those who maintained higher daily movement showed substantially lower symptom severity compared with similarly at-risk but less active peers. In other words, regular activity appeared to dampen the expected clinical expression of genetic liability.
Biologically, several plausible mechanisms could underlie this protective effect. Aerobic exercise promotes hippocampal neurogenesis and elevates brain-derived neurotrophic factor (BDNF), reduces systemic inflammation, and helps normalize stress-response systems such as the hypothalamic-pituitary-adrenal (HPA) axis—pathways often implicated in depression and influenced by genetic risk.
Toward Tailored, Precision Lifestyle Prescriptions
Although this study focused on adults in the All of Us cohort, Brown’s wider research program is examining movement behaviors across developmental windows—especially adolescence and emerging adulthood, periods that coincide with rising rates of anxiety and depression and with declines in physical activity.
Integrating wearable telemetry and genomics moves clinical practice closer to personalized lifestyle prescriptions. The findings suggest clinicians could one day use a patient’s genetic profile together with wearable activity data to recommend specific daily step goals or activity durations aimed at lowering symptom severity or reducing risk.
“There is no single solution that fits everyone,” Brown noted. “Data from programs like All of Us help us identify who is most vulnerable and tailor lifestyle guidance to their biological profile. This study represents progress toward more individualized approaches to mental health prevention and management.”
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was provided by our staff.
About this genetics and depression Research:
- Media Contact: Rafael Garcia
- Source: Kansas State University
- Image Credit: Image credited to Neuroscience News
- Original Research is Open Access: Nature Mental Health (Oct 2, 2026). “Associations and interactions between genetic vulnerability and physical activity with MDD in the All of Us Research Program.” Authors: Qiliang He, Jennifer Zhang, Christopher G. Beevers & Denver M. Y. Brown.
- DOI: 10.1038/s41593-026-02490-y
Abstract
Associations and interactions between genetic vulnerability and physical activity with MDD in the All of Us Research Program
Both genetic liability and physical activity are established contributors to major depressive disorder, but large-scale studies that combine device-assessed activity with genomic risk are scarce. Prior gene–environment studies have largely examined MDD onset rather than symptom severity.
This analysis included 23,517 All of Us participants (mean age ~56 years; range 18–92; 67.2% female) with whole-genome sequencing and long-term Fitbit-derived physical activity (mean wear time 582 days). Physical activity was measured as daily minutes of MVPA and step counts. MDD was defined using a dual-source phenotype that combined electronic health records with self-reported lifetime diagnosis.
Regression models tested main and interaction effects of polygenic risk scores and physical activity while adjusting for demographic covariates. Across all activity metrics, higher polygenic risk was associated with greater odds of MDD diagnosis, and higher physical activity was associated with lower risk. No significant interactions emerged for MDD onset.
However, when examining symptom severity derived from electronic health records, both polygenic risk and physical activity had significant main effects, and consistent negative interactions were observed across activity measures and severity definitions. These interactions indicate that increased physical activity attenuated the relationship between genetic risk and depressive symptom burden, and the patterns remained robust across multiple model specifications.
Together, these results imply that genetic and behavioral factors largely act independently in determining MDD onset but interact in shaping symptom expression. Physical activity emerges as a potential modifier of genetic vulnerability and a promising target for precision mental health interventions.
